Company intelligence / Profile preview

CliniStem

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

CliniStem is a biotechnology company focused on developing advanced regenerative medicine therapies using adult stem cells. The company specializes in the isolation and clinical application of mesenchymal stem cells (MSCs) to treat chronic conditions such as critical limb ischemia and diabetic foot ulcers. CliniStem's proprietary technology aims to provide scalable and standardized cell-based treatments that promote vascularization and tissue repair. By leveraging its expertise in cell biology and clinical development, the company seeks to address significant unmet medical needs in the cardiovascular and wound care sectors.

Therapeutic areas: EndocrinologyCardiovascularDermatology
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on CliniStem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CliniStem.

Explore the full profile